Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Montpelier Re Holdings Ltd. ( MRH - Analyst Report ) reported third quarter 2012 operating income of 85 cents per share, surpassing the Zacks Consensus Estimate by 20 cents. Earnings strongly rebounded from a loss of 40 cents incurred in the prior-year quarter. Operating income of $48.5 million, compared favorably with loss of $24.9 million in third quarter 2011.
Including net realized investment gains of $14.9 million, net unrealized investment gains of $18.3 million, net losses from investment-related derivative instruments of $2.1 million, net foreign exchange losses of $10.8 million and net gains from foreign exchange-related derivative instruments of $2.9 million, the company reported net income of $72 million or $1.25 per share, reversing the loss of $66.2 million or $1.07 per share in the third quarter of 2011.
Operational Update
Gross premiums written declined 21% year over year. Net insurance and reinsurance premiums earned waned 1.9% year over year to $153 million in the quarter.
Montpelier booked underwriting profit of $41.7 million in the quarter, reversing the loss of $33.5 million in the year-ago quarter.
Net investment income in the quarter came in at $15.5 million, down 8.8% from $17.0 million in the year ago-quarter.
The loss ratio in the quarter was 37% compared with 89.0% in the year-ago quarter. Reported quarter loss ratio includes $16 million of favorable prior-year loss reserve movements, offset by $16 million loss estimate for a number of smaller catastrophe events.
The combined ratio in the quarter was 72.7%, a stark improvement from 121.5% reported in the year-ago quarter.
Financial Update
Montpelier exited the quarter with cash and cash equivalents of $414.3 million, up 21.7% from 2011-end.
At quarter end, the debt level slightly increased to $327.9 million from $327.8 million at the end of 2011.
Book value per share as of September 30, 2012, was $26.61, nearly 20% higher than $22.18 as of September 30, 2011.
Share Repurchase
Montpelier spent $22 million to buyback approximately 1.04 million shares in the third quarter of 2012.
Our Take
Montpelier is well positioned to deliver robust numbers going forward, given its increased exposure in the property catastrophe lines of business. Also, focusing on underwriting operations, augmenting capital flexibility, and strengthening its competitive position augur well going forward. Moreover, the $300 million senior debt refinancing supports enhanced capital flexibility. It also scores strongly with the rating agencies.
The company also benefits from tax exemptions in Bermuda, as no income taxes are levied there. Additionally, Bermuda Ministry of Finance has assured exemption of Bermuda-imposed income, withholding and capital gains taxes until 2035 on all Bermuda-based subsidiaries.
The quantitative Zacks #2 Rank (short-term Buy rating) for the company indicates a slight boost on the stock over the near term.
RenaissanceRe Holdings Ltd. ( RNR - Analyst Report ) , a close competitor of Montpelier, is scheduled to release its third quarter results on November 1 after the bell. It also carries a Zacks #2 Rank.
Read the full Analyst Report on MRH
Read the full Analyst Report on RNR